Clinical research has demonstrated that GLP-1 medications effectively support metabolic health in women across all reproductive stages, including premenopausal, perimenopausal, and postmenopausal women
Nello studio SURMOUNT-5, lunico trial testa a testa disponibile tra i due farmaci, semaglutide alla dose standard di 1,7 o 2,4 mg ha prodotto una perdita di peso del 13,7%, contro il 20,2% del tirzepatide 10 o 15 mg (Aronne et al., 2025)
I wasnt stressed, lost weight, or have any health issues
Because it helps with weight loss, some people argue that it might give an advantage to athletes in weight-class sports like wrestling, boxing, or mixed martial arts (MMA)
Temperature sensitivity, dosing schedules, documentation